Cleared Special

LIPOSAT BASIC (INFILTRATION PUMP), MODEL 92-007 688 (K072793) - FDA 510(k) Clearance

Class II General & Plastic Surgery device cleared through the Special 510(k) pathway - typically does not require clinical trials.

Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Mar 2008
Decision
155d
Days
Class 2
Risk

K072793 is an FDA 510(k) clearance for the LIPOSAT BASIC (INFILTRATION PUMP), MODEL 92-007 688. Classified as System, Suction, Lipoplasty For Removal (product code QPB), Class II - Special Controls.

Submitted by Moeller Medical GmbH & Co. KG (Coto De Caza, US). The FDA issued a Cleared decision on March 4, 2008 after a review of 155 days - an extended review cycle.

This device falls under the General & Plastic Surgery FDA review panel, regulated under 21 CFR 878.5040 - the FDA general and plastic surgery device framework. As a Special 510(k), this submission covers a manufacturer modification to an existing cleared device rather than a new device introduction.

Device pattern: Iterative device modification. Standard predicate reliance. This Special 510(k) clearance confirms that the manufacturer's modifications remained within the established regulatory envelope of the original cleared device.

View all Moeller Medical GmbH & Co. KG devices

Submission Details

510(k) Number K072793 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received October 01, 2007
Decision Date March 04, 2008
Days to Decision 155 days
Submission Type Special
Review Panel General & Plastic Surgery (SU)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
40d slower than avg
Panel avg: 115d · This submission: 155d
Pathway characteristics
Modification to existing cleared device.

Device Classification

Product Code QPB System, Suction, Lipoplasty For Removal
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 878.5040
Definition A Suction Lipoplasty System Is A Device Intended For The Removal Of Adipose Tissue For Purposes Of Aesthetic Body Contouring
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most General & Plastic Surgery devices follow this clearance model.

Regulatory Peers - QPB System, Suction, Lipoplasty For Removal

All 56
Devices cleared under the same product code (QPB) and FDA review panel - the closest regulatory comparables to K072793.
AYON Body Contouring System™ (AYON SYSTEM)
K253396 · Apyx Medical Corporation · May 2026
LSSA (NP-200)
K252495 · Newpong Co., Ltd. · Apr 2026
AYON Body Contouring System (AYON SYSTEM)
K244050 · Apyx Medical Corporation · May 2025
PAL 7020 Console
K244026 · Microaire Surgical Instruments, LLC · Apr 2025
PAL Aspiration System
K242804 · Microaire Surgical Instruments, LLC · Dec 2024
AirSculpt Body Contouring System (AIRS-1-SYS)
K241835 · Cellmyx · Nov 2024